Development of acute hepatotoxicity following the first dose of paliperidone palmitate: A case report
Dusunen Adam - The Journal of Psychiatry and Neurological Sciences, cilt.33, sa.1, ss.92-95, 2020 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 33 Sayı: 1
- Basım Tarihi: 2020
- Doi Numarası: 10.14744/dajpns.2019.00065
- Dergi Adı: Dusunen Adam - The Journal of Psychiatry and Neurological Sciences
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Psycinfo, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.92-95
- Anahtar Kelimeler: Hepatotoxicity, liver enzymes, paliperidone palmitate
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Paliperidone palmitate (PP) is a long-acting antipsychotic administered intramuscularly once a month in the acute and maintenance treatments of schizophrenia. It has been reported to be successful especially in patients with poor oral drug compliance. The most common side effects are dizziness, sleepiness, anxiety, injection site reactions, and extrapyramidal system symptoms. The aim of this study is to draw attention to a rare side effect of PP and contribute to the literature by presenting a case of high fever and high liver function tests after application of the first dose.